Bianca F Goemans Selected Research

nuclear pore complex protein 98

1/2023

Comprehensive molecular and clinical characterization of NUP98 fusions in pediatric acute myeloid leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bianca F Goemans Research Topics

Disease

8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 11/2005
5	Neoplasms (Cancer) 04/2024 - 11/2005
3	Leukemia 01/2023 - 11/2005
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 11/2005
2	Mucormycosis 01/2023 - 01/2022
1	Residual Neoplasm 01/2023
1	Cardiotoxicity 11/2006

Drug/Important Bio-Agent (IBA)

1	nuclear pore complex protein 98IBA 01/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	Gemtuzumab (Mylotarg)FDA Link 01/2023
1	Inotuzumab OzogamicinIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 11/2022
1	Tyrosine Kinase InhibitorsIBA 10/2010
1	SU 11657IBA 10/2010
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 02/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2008
1	Vascular Endothelial Growth Factor CIBA 02/2008
1	Daunorubicin (Cerubidine)FDA LinkGeneric 11/2006
1	AnthracyclinesIBA 11/2006
1	tipifarnib (R115777)IBA 11/2005
1	TransferasesIBA 11/2005

Therapy/Procedure

7	Therapeutics 04/2024 - 10/2010
1	Blood Component Removal (Apheresis) 01/2023
1	Transplantation 01/2023
1	Stem Cell Transplantation 01/2023
1	Drug Therapy (Chemotherapy) 09/2008